Details of the Drug

General Information of Drug (ID: DMI17F3)

Drug Name

HCV-371

Synonyms

HCV-371; NBNLIKBZ5N; UNII-NBNLIKBZ5N; 2-[(1R)-5-cyano-8-methyl-1-propyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid; Pyrano[3,4-b]indole-1-acetic acid, 5-cyano-1,3,4,9-tetrahydro-8-methyl-1-propyl-, (1R)-; Pyrano(3,4-b)indole-1-acetic acid, 5-cyano-1,3,4,9-tetrahydro-8-methyl-1-propyl-, (1R)-; AC1MHXB1; CHEMBL390282; SCHEMBL3487701; (5-Cyano-8-methyl-1-propyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis C virus infection	1E51.1	Discontinued in Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C18H20N2O3
Canonical SMILES: CCCC1(C2=C(CCO1)C3=C(C=CC(=C3N2)C)C#N)CC(=O)O
InChI: 1S/C18H20N2O3/c1-3-7-18(9-14(21)22)17-13(6-8-23-18)15-12(10-19)5-4-11(2)16(15)20-17/h4-5,20H,3,6-9H2,1-2H3,(H,21,22)/t18-/m1/s1
InChIKey: JXZYSNWHGBGZAI-GOSISDBHSA-N

Cross-matching ID

PubChem CID: 3013096
CAS Number: 463941-20-0
TTD ID: D0H9FX

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018541)